BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 34745124)

  • 41. Immune-Related Genes' Prognostic, Therapeutic and Diagnostic Value in Ovarian Cancer Immune-Related Gene Biomarker in Ovarian Cancer.
    Ding B; Yan W; Shen S; Meng D; Chen X; Wang S; Shen Y
    Cancer Control; 2023; 30():10732748231168756. PubMed ID: 37078136
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tumor Mutation Burden Predicts Relapse in Papillary Thyroid Carcinoma With Changes in Genes and Immune Microenvironment.
    Guo M; Chen Z; Li Y; Li S; Shen F; Gan X; Feng J; Cai W; Liu Q; Xu B
    Front Endocrinol (Lausanne); 2021; 12():674616. PubMed ID: 34248843
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of the Immune Cell Infiltration Landscape in Esophageal Squamous Cell Carcinoma.
    Sui Z; Wu X; Du L; Wang H; Yuan L; Zhang JV; Yu Z
    Front Oncol; 2022; 12():879326. PubMed ID: 35875070
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
    Zuo S; Wei M; Wang S; Dong J; Wei J
    Front Immunol; 2020; 11():1218. PubMed ID: 32714316
    [No Abstract]   [Full Text] [Related]  

  • 45. Prognostic value of tumor immune cell infiltration patterns in colon adenocarcinoma based on systematic bioinformatics analysis.
    Xu H; Xu Q; Yin L
    Cancer Cell Int; 2021 Jul; 21(1):344. PubMed ID: 34217290
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Overexpression of
    Jiang S; Yang Y; Zhang Y; Ye Q; Song J; Zheng M; Li X
    Dis Markers; 2022; 2022():9719671. PubMed ID: 35186171
    [TBL] [Abstract][Full Text] [Related]  

  • 47. S100A2 Is a Prognostic Biomarker Involved in Immune Infiltration and Predict Immunotherapy Response in Pancreatic Cancer.
    Chen Y; Wang C; Song J; Xu R; Ruze R; Zhao Y
    Front Immunol; 2021; 12():758004. PubMed ID: 34887861
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of STEAP3-based molecular subtype and risk model in ovarian cancer.
    Zhao Z; Sun C; Hou J; Yu P; Wei Y; Bai R; Yang P
    J Ovarian Res; 2023 Jun; 16(1):126. PubMed ID: 37386521
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immune microenvironment infiltration landscape and immune-related subtypes in prostate cancer.
    Wu W; Wang X; Le W; Lu C; Li H; Zhu Y; Chen X; An W; Xu C; Wu Q; Wang L
    Front Immunol; 2022; 13():1001297. PubMed ID: 36700224
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification and validation of an immune prognostic signature in colorectal cancer.
    Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
    Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of immune microenvironment subtypes that predicted the prognosis of patients with ovarian cancer.
    Wang X; Li X; Wang X
    J Cell Mol Med; 2021 Apr; 25(8):4053-4061. PubMed ID: 33675171
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of copper metabolism-related subtypes and establishment of the prognostic model in ovarian cancer.
    Zhao S; Zhang X; Gao F; Chi H; Zhang J; Xia Z; Cheng C; Liu J
    Front Endocrinol (Lausanne); 2023; 14():1145797. PubMed ID: 36950684
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of the Immune Microenvironmental Landscape of Lung Squamous Cell Carcinoma with Immune Cell Infiltration.
    Chen C; Tang D; Gu C; Wang B; Yao Y; Wang R; Zhang H; Gao W
    Dis Markers; 2022; 2022():2361507. PubMed ID: 36411824
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of the Immune Cell Infiltration Landscape of Thyroid Cancer for Improved Immunotherapy.
    Gong J; Jin B; Shang L; Liu N
    Front Mol Biosci; 2021; 8():714053. PubMed ID: 34790698
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Significance of tumor mutation burden and immune infiltration in thymic epithelial tumors.
    Wang ZM; Xu QR; Kaul D; Ismail M; Badakhshi H
    Thorac Cancer; 2021 Jul; 12(13):1995-2006. PubMed ID: 34033229
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Immunological Role of CDK4/6 and Potential Mechanism Exploration in Ovarian Cancer.
    Liu C; Huang Y; Cui Y; Zhou J; Qin X; Zhang L; Li X; Li Y; Guo E; Yang B; Li X; Fan J; Li X; Fu Y; Liu S; Hu D; Xiao R; Wang Z; Dou Y; Wang W; Li W; Yang X; Liu J; Peng W; Qin T; You L; Lu F; Sun C
    Front Immunol; 2021; 12():799171. PubMed ID: 35095879
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Construction of immune cell infiltration score model to assess prognostic ability of tumor immune environment in lung adenocarcinoma.
    Tian J; Fu C; Peng Q; Yang J; Fan X; Zeng X; Qing W; Wu Y
    Am J Transl Res; 2023; 15(3):1730-1743. PubMed ID: 37056847
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic value of immune-related cells and genes in the tumor microenvironment of ovarian cancer, especially CST4.
    Wang S; Wang C; Liu O; Hu Y; Li X; Lin B
    Life Sci; 2021 Jul; 277():119461. PubMed ID: 33811900
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Machine learning developed a CD8
    Chen R; Zheng Y; Fei C; Ye J; Fei H
    Sci Rep; 2024 Mar; 14(1):5794. PubMed ID: 38461331
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of Immune Cell Infiltration Landscape and Their Prognostic Significance in Uveal Melanoma.
    Zhao H; Chen Y; Shen P; Gong L
    Front Cell Dev Biol; 2021; 9():713569. PubMed ID: 34513843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.